The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan, C.-C., et al. (1999) · Science · doi:10.1126/science.283.5407.1544 · Cited by 2,210
Self-citationPerturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Cell · doi:10.1016/0092-8674(86)90779-8 · Cited by 1,006
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Src family kinases in tumor progression and metastasis
Summy, J. M., & Gallick, G. E. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023772912750 · Cited by 827
Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting
(2005) · Advances in Cancer Research · doi:10.1016/s0065-230x(05)94002-5 · Cited by 823
A quantitative protein interaction network for the ErbB receptors using protein microarrays
Jones, R. B., Gordus, A., Krall, J. A., & MacBeath, G. (2006) · Nature · doi:10.1038/nature04177 · Cited by 727
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
Citri, A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00101-5 · Cited by 595
Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 590
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases
Östman, A. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)01990-0 · Cited by 383
Lee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
Self-citationTarget-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
Normanno, N., Bianco, C., De Luca, A., Maiello, M. R., & Salomon, D. S. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100001 · Cited by 336
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329
Bjorge, J. D., Pang, A., & Fujita, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004852200 · Cited by 316
Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
Bargmann, C. I., & Weinberg, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03044.x · Cited by 315
Lane, H. A., Beuvink, I., Motoyama, A. B., Daly, J. M., Neve, R. M., & Hynes, N. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3210-3223.2000 · Cited by 298
Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP
Bourdeau, A., Dubé, N., & Tremblay, M. L. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.001 · Cited by 243
Self-citationThe RasGAP-Binding Protein p62dok Is a Mediator of Inhibitory FcγRIIB Signals in B Cells
Tamir, I., Stolpa, J. C., Helgason, C. D., Nakamura, K., Bruhns, P., Daeron, M., & Cambier, J. C. (2000) · Immunity · doi:10.1016/s1074-7613(00)80187-9 · Cited by 241
Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors.
Siegel, P. M., Dankort, D. L., Hardy, W. R., & Muller, W. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7068 · Cited by 213
Self-citationMechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2
Liu, H., Radisky, D. C., Nelson, C. M., Zhang, H., Fata, J. E., Roth, R. A., & Bissell, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511342103 · Cited by 202
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink, A. E. G., Busse, D., Flanagan, W. M., Yakes, F. M., & Arteaga, C. L. (2001) · PubMed · Cited by 178
Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells
Neve, R. M., Sutterlüty, H., Pullen, N., Lane, H. A., Daly, J. M., Krek, W., & Hynes, N. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203470 · Cited by 158
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
Lin, H.-J., Hsieh, F.-C., Song, H., & Lin, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602862 · Cited by 155
Transgenic mouse models of human breast cancer
Hutchinson, J. N., & Muller, W. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203970 · Cited by 147
Self-citationEffect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene.
Brown-Shimer, S. L., Johnson, K. A., HILL, D. E., et al. (1992) · PubMed · Cited by 143
The role of protein tyrosine phosphatase 1B in Ras signaling
Dubé, N., Cheng, A., & Tremblay, M. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304242101 · Cited by 141
Self-citationA novel splice variant ofHER2 with increased transformation activity
Kwong, K. Y., & Hung, M. (1998) · Molecular Carcinogenesis · Cited by 139
Muraoka, R. S., Lenferink, A. E. G., Law, B. K., Hamilton, E., Brantley, D. M., Roebuck, L. R., & Arteaga, C. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2204-2219.2002 · Cited by 116
Zhai, Y. F., Beittenmiller, H. F., Wang, B., et al. (1993) · PubMed · Cited by 105
Cheng, A., Bal, G. S., Kennedy, B. P., & Tremblay, M. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009734200 · Cited by 101
Self-citationBaselga, J. M., & Norton, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00066-1 · Cited by 99
Dubé, N., Bourdeau, A., Heinonen, K. M., Cheng, A., Lee-Loy, A., & Tremblay, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1353 · Cited by 98
Self-citationOverexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas
Wiener, J. R., Hurteau, J. A., Kerns, B.-J. M., Whitaker, R. S., Conaway, M. R., Berchuck, A., & Bast, R. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70118-0 · Cited by 84
Transformation Suppression by Protein Tyrosine Phosphatase 1B Requires a Functional SH3 Ligand
Liu, F., Sells, M. A., & Chernoff, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.250 · Cited by 73
Andrechek, E. R., Laing, M. A., Girgis-Gabardo, A., Siegel, P. M., Cardiff, R. D., & Muller, W. J. (2003) · PubMed · Cited by 65
Self-citationResidues Distant from the Active Site Influence Protein-tyrosine Phosphatase 1B Inhibitor Binding
Montalibet, J., Skorey, K., McKay, D., Scapin, G., Asante‐Appiah, E., & Kennedy, B. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511546200 · Cited by 63
Self-citationZhao, M., Janas, J. A., Niki, M., Pandolfi, P. P., & Aelst, L. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2479-2489.2006 · Cited by 62
Beyond the Metabolic Function of PTP1B
Dubé, N., & Tremblay, M. L. (2004) · Cell Cycle · doi:10.4161/cc.3.5.851 · Cited by 34
Self-citationThe Future of ErbB-1 and ErbB-2 Pathway Inhibition in Breast Cancer: Targeting Multiple Receptors
Slamon, D. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_3-1 · Cited by 26
Essential function for ErbB3 in breast cancer proliferation
Pérez‐Nadales, E., & Lloyd, A. C. (2004) · Breast Cancer Research · doi:10.1186/bcr792 · Cited by 13
Cited by
EGF receptor trafficking: consequences for signaling and cancer
Tomas, A., Futter, C. E., & Eden, E. R. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.002 · Cited by 779
The epidermal growth factor receptor family: Biology driving targeted therapeutics
Wieduwilt, M. J., & Moasser, M. M. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7440-8 · Cited by 751
Inside the human cancer tyrosine phosphatome
Julien, S. G., Dubé, N., Hardy, S., & Tremblay, M. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2980 · Cited by 495
Self-citationTonks, N. K. (2013) · The FEBS Journal · doi:10.1111/febs.12077 · Cited by 432
Targeting the disordered C terminus of PTP1B with an allosteric inhibitor
Krishnan, N., Koveal, D., Miller, D. H., Xue, B., Akshinthala, S. D., Kragelj, J., Jensen, M. R., Gauss, C.-M., Page, R., Blackledge, M., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1528 · Cited by 372
Metadata
- Authors
- Julien, S. G., Dubé, N., Read, M., Penney, J., Paquet, M., Han, Y., Kennedy, B. P., Muller, W. J., & Tremblay, M. L.
- Venue
- Nature Genetics
- Published
- 2007-01-28
- Volume
- 39
- Issue
- 3
- Pages
- 338-346
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2099220382
- Cited by
- 316
- References
- 42
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.